All In Biotech

Drug Trial Radar · NCT05483907

To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF

A Phase 2, Randomized, Double-blind, Placebo-controlled, 24-Week Study to Evaluate the Efficacy, Safety, and Tolerability of BBT-877, as Mono- or add-on Therapy, in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Last checked: Nov 19, 2026Latest source record: Apr 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 129 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

129

Actual

Start

Apr 12, 2023

Primary completion

Jan 26, 2025

Study completion Feb 23, 2025

Sponsor

Lead sponsor
Bridge Biotherapeutics, Inc.Industry
Sponsor type
Industry
First posted
Aug 2, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled, study to evaluate the efficacy, safety, and tolerability of 200 mg twice daily (BID) of BBT-877 in patients with IPF, with or without AF approved background therapies (pirfenidone or nintedanib).

Conditions

  • Idiopathic Pulmonary Fibrosis

Interventions

  • BBT-877Drug

    BBT-877 24 weeks + Follow-up 4 weeks

  • PlaceboDrug

    Placebo 24 weeks + Follow-up 4 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. In patients with IPF by measuring the reduction in forced vital capacity (FVC) in mL decline compared to placeboTime frame: After 24 weeks of treatment

Locations

44 sites in 5 countries. Site status is shown where the registry gives one.

  • Pulmonary Associates P.A.

    Phoenix, Arizona

  • Southern Arizona VA Health Care System - NAVREF - PPDS

    Tucson, Arizona

  • Keck Medical Center of USC

    Los Angeles, California

  • VA Palo Alto Health Care System

    Palo Alto, California

  • National Jewish Health Main Campus

    Denver, Colorado

  • St. Francis Medical Institute - Clinedge

    Clearwater, Florida

  • Renstar Medical Research

    Ocala, Florida

  • Central Florida Pulmonary Group PA

    Orlando, Florida

  • Augusta University

    Augusta, Georgia

  • Northwestern Memorial Hospital

    Chicago, Illinois

  • Loyola University Medical Center

    Maywood, Illinois

  • The Lung Research Center, LLC

    Chesterfield, Missouri

  • Hannibal Regional Healthcare System-HRMG-Hannibal

    Hannibal, Missouri

  • Medical University of South Carolina

    Charleston, South Carolina

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • Premier Pulmonary Critical Care & Sleep Medicine

    Denison, Texas

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia

  • Royal Brisbane & Women's Hospital

    Herston, Queensland, Australia

  • Institute for Respiratory Health

    Nedlands, Western Australia, Australia

  • Barzilai Medical Center

    Petah Tikva, Israel

  • Rabin Medical Center

    Petah Tikva, Israel

  • Kaplan Medical Center

    Rehovot, Israel

  • Meir Medical Center

    Kfar Saba, Central District, Israel

  • Lady Davis Carmel Medical Center

    Haifa, Haifa District, Israel

  • Hadassah Medical Center

    Jerusalem, Jerusalem, Israel

  • Tel Aviv Sourasky Medical Center

    Ashkelon, Southern District, Israel

  • Sheba Medical Center

    Ramat Gan, Tel Aviv, Israel

  • Vitamed Galaj i Cichomski sp.j.

    Bydgoszcz, Poland

  • Centrum Dentystyczno Lekarskie Promedica Joanna Markiewicz

    Będzin, Silesian Voivodeship, Poland

  • Inje University Haeundae Paik Hospital

    Busan, South Korea

  • Kyung Hee University Hospital

    Seoul, South Korea

  • Severance Hospital Yonsei University

    Seoul, South Korea

  • Soon Chun Hyang University Hospital Seoul

    Cheonan, Chungcheongnam-do, South Korea

  • Samsung Medical Center

    Seoul, Gangnam-gu, South Korea

  • The Catholic University of Korea, Bucheon St. Mary's Hospital

    Bucheon-si, Gyeonggi-do, South Korea

  • CHA Bundang Medical Center, CHA University

    Seongnam-si, Gyeonggi-do, South Korea

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, South Korea

  • Ajou University Hospital

    Suwon, Gyeonggi-do, South Korea

  • Myongji Hospital

    Goyang-si, Gyeonggido, South Korea

  • Pusan National University Yangsan Hospital

    Yangsan, Gyeongsangnam-do, South Korea

Showing 40 of 44 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.